0001412486 2025-09-19 2025-09-19 0001412486 1 2025-09-19 2025-09-19 0001412486 2 2025-09-19 2025-09-19 iso4217:USD shares iso4217:USD shares pure 0001412486 EX-FILING FEES 0.0001531 0.0001531 S-1 S-1 Cocrystal Pharma, Inc. Equity Common Stock, par value $0.001 per share true 2764710 1.50 4147065.00 634.92 false Equity Warrants to Purchase Common Stock true 207353 2.125 440625.13 67.46 false false 4587690.13 702.38 702.38 Consists of (i) 2,764,710 shares of common stock issuable upon conversion of investor warrants held by investors (“Investor Warrants”); and (ii) 207,353 shares of common stock issuable upon exercise of placement agent warrants (the “PA Warrants”), in each case as more particularly described in the registration statement on Form S-1 to which this filing fee table relates. Also includes such indeterminate number of additional shares of common stock issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction, including, but not limited to, as a result of the anti-dilution provisions contained in the securities.<span id="xdx_C0E_gIFON-XOW_zNUAnpos9ee2">Pursuant to Rule 457(g) under the Securities Act of 1933, and solely for the purpose of calculating the registration fee, the proposed maximum offering price per share of common stock issuable upon exercise of the Investor Warrants which are exercisable at $1.50 per share and the PA Warrants which are exercisable at $2.125 per share is in each case estimated based upon the higher of (a) the exercise price of such Warrants, as applicable, and (b) $1.385, which is the average of the high and low sale prices of the shares of common stock as of September 15, 2025, as reported on The Nasdaq Capital Market.</span> Consists of (i) 2,764,710 shares of common stock issuable upon conversion of investor warrants held by investors (“Investor Warrants”); and (ii) 207,353 shares of common stock issuable upon exercise of placement agent warrants (the “PA Warrants”), in each case as more particularly described in the registration statement on Form S-1 to which this filing fee table relates. Also includes such indeterminate number of additional shares of common stock issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction, including, but not limited to, as a result of the anti-dilution provisions contained in the securities.Pursuant to Rule 457(g) under the Securities Act of 1933, and solely for the purpose of calculating the registration fee, the proposed maximum offering price per share of common stock issuable upon exercise of the Investor Warrants which are exercisable at $1.50 per share and the PA Warrants which are exercisable at $2.125 per share is in each case estimated based upon the higher of (a) the exercise price of such Warrants, as applicable, and (b) $1.385, which is the average of the high and low sale prices of the shares of common stock as of September 15, 2025, as reported on The Nasdaq Capital Market. N/A N/A